Advisory Board and Editors Translational Medicine
Giuseppe Lanza
Dr. Giuseppe Lanza was born in Catania (Italy) in 1982. He currently works as a Senior Academic Researcher and Assistant Professor at the University of Catania (Italy). After graduation with honours in Medicine, he trained at the School of Neurology and got the international PhD at the same University. As visiting Clinical Research Fellow, he further trained at the Department of Neuroscience and Clinical Neurophysiology of the Newcastle University (UK). In 2013 he was selected for a Scientific Fellowship promoted by the European Federation of Neurological Societies (EFNS). From 2013 to October 2018, he worked as a Consultant Neurologist at the “Oasi Research Institute–IRCCS” in Troina (Italy), which is a Collaborating Center of the World Health Organization (WHO), and where now he currently holds the position of Chief of the Clinical Neurophysiology Research Unit. From 2015 to October 2018, he taught Neurology at the University of Enna (Italy). He has authored more than 150 publications in internationally-indexed peer-reviewed Journals and Conferences or Meetings, and he currently serves as Editor and invited Reviewer of several international Journals. More recently, he has obtained the Master of Science in Clinical Research and the National Scientific Qualification as Full Professor (procedure for the Italian University Professor recruiting, based on criteria of scientific qualification).
B Duncan X Lascelles
After graduating from the veterinary program at the University of Bristol, U.K., with honors, Dr. Lascelles completed a PhD in aspects of pre-emptive/perioperative analgesia at the University of Bristol. After an internship there, he completed his surgical residency at the University of Cambridge, U.K. and then a Fellowship in Oncological Surgery at Colorado State University. He is currently Professor in Small Animal Surgery and Pain Management at North Carolina State University.
Li Li
Dr. Li Li (David) is a general physician in Guangzhou First People’s Hospital and is actively involved in the educational affairs on both the departmental and hospital level. Dr. Li received his MD degree from Tongji Medical College of Huazhong University of Science and Technology (HUST). He later went to Hong Kong and received his MPhil and PhD degree from the University of Hong Kong (HKU). He is the first one to have been certified by SSH as a Certified Healthcare Simulation Educator (CHSE) in Mainland China. In 2020, Dr. Li was the first one in China to be invited to become a member of the 4th cohort of SSH Academy Fellow (FSSH).
Dr. Li is one of the most active SP educators in Central and Southern part of China and has provided opportunities for different educational programs to engage SPs as part of their educational system. He works closely with organizations such as the National Medical Examination Center (NMEC) to promote the engagement of simulation approaches and SPs into the National Medical Licensure Examinations in China.
Dr. Li also serves as the Secretary-General of Committee for Healthcare Simulation, Wu Jieping Medical Foundation, the leading Non-Profit Organization in the medical community in China.
Ning Li
Prof. Li received his Medical Doctorate in 2005 as an outstanding graduate of the Chinese Union Medical University (CUMU). In the same year, he worked in the Department of Thoracic Surgery at the Cancer Hospital of the Chinese Academy of Medical Sciences, where he served as an attending physician, deputy chief physician, and was appointed Chief Physician in 2019. He has a solid theoretical foundation and excellent research ability, and has accumulated rich clinical experience during my work. In 2017, he took over as the Director of the Office of Drug Clinical Trial Research Center, and his outstanding achievements in the management of clinical trial institutions and clinical and translational research, and is currently served as the chief expert of China GCP platform and Leading PI of international multicenter clinical trials of anti-cancer drug discovery. He is committed to new anti-tumor drug research, real-world research, full chain translation research of clinical trials, precision treatment of rare tumors and tumor big data research. His H-Index is 44 based on Web of Science. As a sub-project leader of the National 973 Major Project, the National Key R&D Program for Precision Medicine, the National Natural Science Foundation of China, the GCP platform leader, and the leader of the 13th and 14th Five-Year Innovation Project, he has undertaken many research projects.
Dominique Lison
Professor of Toxicology and Occupational Medicine at the Catholic University of Louvain and Director of the Louvain Centre of Toxicology and Applied Pharmacology in Brussels, Belgium.
Dongliang Liu
Dr. Dongliang Liu is a Postdoctoral Associate in the Department of Surgery at the Baylor College of Medicine. His research interests include: Cancer therapy, especially for pancreatic cancer immunotherapy; Chimeric virus-like particles (VLP) vaccine, especially for cancer vaccines; Novel antibiotics development including antimicrobial peptides; Epitomics and multi-epitope peptide vaccine development for pathogenic viruses.
Laurent Metzinger
Laurent Metzinger has completed his PhD in Biological Sciences and Pharmaceutical studies in Strasbourg, France and was a postdoctoral fellow from the University of Oxford (UK) in a leading lab on Duchenne muscular Dystrophy (Pr. Kay Davies). He works on microRNA regulation in the HEMATIM team in Amiens, and focuses on anemia and related vascular disorders associated with Chronic Kidney DIsease. He has authored some of the first papers showing a role for microRNAs in CKD and published in reputed journals, including Nature and Cell. He teaches Biochemistry, Genetics and Molecular Biology in the Pharmacy School of Amiens (Université de Picardie Jules Verne).
Carla Minoia
Dr. Carla Minoia is a MD at IRCCS Istituto Tumori "Giovanni Paolo II" Bari (Italy). Her PhD involved clinical research on lymphoma, survivorship, and quality of life.
Biswapriya Biswavas Misra
Interested in metabolomics and genomics of diseases! My current work is focused on generating quality metabolomics datasets leveraging the high-resolution mass-spectrometry (GC-Orbitrap-MS and LC-Orbitrap-MS) and occasionally NMR datasets to combine with other -omics layers such as genomics (transcriptomics, epigenetics), proteomics, and clinical data sets to provide insights in metabolic changes that are associated with human and non-human primate wellness and disease conditions, specifically metabolic syndromes such as atherosclerosis, diabetes, obesity, and Alzheimer’s disease.
Thimios A Mitsiadis
Professor of Oral Biology in the Medical Faculty at the University of Zurich, Switzerland since 2006. Research in the fields of stem cells, genetics, molecular and experimental biology related to orofacial developmental and regeneration processes.
DDS degree from the Dental Faculty of the Kapodistrion University of Athens (Greece), Master degree for Immunology, Genetics and Differentiation, and PhD in Developmental Biology from the University of Lyon (France). Postdoctoral studies at the University of Helsinki (Finland), Karolinksa Nobel Institute (Stockholm, Sweden) and Yale University (USA). Previously Professor at the Mediterranean University (Marseilles, France), Visiting Professor at the Ecole Normale Superieure of Lyon (France), Clinical Senior Lecturer at King's College London (UK), Visiting Professor at the Polytechnic University of Marche (Ancona, Italy), Visiting Professor at the Second University of Napoli (Napoli, Italy). Chief-Editor of the “Frontiers of Craniofacial Biology and Dental Research”, Associate Editor of “Stem Cell Research”, Scientific Editor of “European Cells & Materials”, and part of the editorial board in additional 8 scientific journals. More than 110 original articles in journals such as “Journal of Cell Biology”, “Development”, “Developmental Biology”, “Nature Genetics”, “Science Signaling”, “Scientific Reports”, “Frontiers in Physiology” and more than 200 keynote and invited lectures.
Ipsita Mohanty
Dr. Ipsita Mohanty is a Research Associate II at the Children's Hospital of Philadelphia Research Institute
Her current research focuses on investigating the molecular mechanisms of nitric oxide signaling pathway at the proteome levels using multipronged approach of mouse genetics, ex vivo mechanistic functional study as well as high throughput mass spectroscopy techniques.
Dr. Mohanty has expertise in pharmacology, physiology, and proteomics with emphasis in intracellular signal transduction and GPCR signaling directed towards designing therapeutic strategies for cardiovascular disorders. Technical cognizance encompasses fields of Smooth Muscle pharmacology, Integrative Physiology, Contraction Physiology, Proteomics, Biochemistry, Molecular Biology, Bioinformatic Data Analysis (and related softwares) for Mass Spectrometry data and In-Vivo skills.
Alessandra Montecucco
Alessandra Montecucco heads a laboratory of the Unit of Molecular and Cellular Biology of the Nucleus at the Institute of Molecular Genetics (IGM) of the Italian National Research Council (CNR). Her research activity is focused on the cellular response to DNA damage and genome integrity.